Our preprint on how de novo miniprotein design has led us to Denasin1, a nanomolar, in vivo-active inhibitor of human ASIC1a is now online. Big thanks to everyone involved, especially project lead Janina, our great UCPH collaborators in the groups of Joe Rogers, Henriette Autzen and Changsi Cai, as well as Nanion und funding sources. Find the details here: [bioRxiv]



